Wetzels JFM - Search Results

1

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient.

Bouwmeester RN, Ter Avest M, Wijnsma KL, Duineveld C, Ter Heine R, Volokhina EB, Van Den Heuvel LPWJ, Wetzels JFM, van de Kar NCAJ. Bouwmeester RN, et al. Among authors: wetzels jfm. Front Immunol. 2021 Jan 15;11:612706. doi: 10.3389/fimmu.2020.612706. eCollection 2020. Front Immunol. 2021. PMID: 33519821 Free PMC article.

2

Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis.

Löwik MM, Hol FA, Steenbergen EJ, Wetzels JF, van den Heuvel LP. Löwik MM, et al. Nephrol Dial Transplant. 2005 Feb;20(2):336-41. doi: 10.1093/ndt/gfh546. Epub 2004 Dec 7. Nephrol Dial Transplant. 2005. PMID: 15585516

3

Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.

Peters HP, van de Kar NC, Wetzels JF. Peters HP, et al. Neth J Med. 2008 Nov;66(10):408-15. Neth J Med. 2008. PMID: 19011266 Free article.

4

Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.

Mutsaers HA, van den Heuvel LP, Ringens LH, Dankers AC, Russel FG, Wetzels JF, Hoenderop JG, Masereeuw R. Mutsaers HA, et al. PLoS One. 2011 Apr 4;6(4):e18438. doi: 10.1371/journal.pone.0018438. PLoS One. 2011. PMID: 21483698 Free PMC article.

5

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC. Westra D, et al. Neth J Med. 2012 Apr;70(3):121-9. Neth J Med. 2012. PMID: 22516576 Free article. Review.

6

Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.

Mutsaers HA, Engelke UF, Wilmer MJ, Wetzels JF, Wevers RA, van den Heuvel LP, Hoenderop JG, Masereeuw R. Mutsaers HA, et al. PLoS One. 2013 Aug 2;8(8):e71199. doi: 10.1371/journal.pone.0071199. Print 2013. PLoS One. 2013. PMID: 23936492 Free PMC article.

7

Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome.

Verhave JC, Westra D, van Hamersvelt HW, van Helden M, van de Kar NC, Wetzels JF. Verhave JC, et al. Neth J Med. 2013 Sep;71(7):342-7. Neth J Med. 2013. PMID: 24038559 Free article.

8

Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.

Verhave JC, Wetzels JF, van de Kar NC. Verhave JC, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv131-41. doi: 10.1093/ndt/gfu235. Nephrol Dial Transplant. 2014. PMID: 25165180 Review.

9

Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome.

Wetzels JF, van de Kar NC. Wetzels JF, et al. Am J Kidney Dis. 2015 Feb;65(2):342. doi: 10.1053/j.ajkd.2014.04.039. Am J Kidney Dis. 2015. PMID: 25616634 No abstract available.

10

Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.

Volokhina EB, van de Kar NC, Bergseth G, van der Velden TJ, Westra D, Wetzels JF, van den Heuvel LP, Mollnes TE. Volokhina EB, et al. Clin Immunol. 2015 Oct;160(2):237-43. doi: 10.1016/j.clim.2015.05.018. Epub 2015 Jun 23. Clin Immunol. 2015. PMID: 26111482 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page